Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 5/5 core metricsLatest reported free cash flow was -$28M.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Free cash flow was negative
Latest reported free cash flow was -$28M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
- No current rule-based risk flags
3 filing-based checks were evaluable.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Revenue expanded
Latest reported annual revenue changed +4.1% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Operating margin improved
Operating margin changed +7.6 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Commission$498Mshare n/a+7.9% yoy
- Medicare$461Mshare n/a+7.8% yoy
- Commission Members Approved During Current Period$445Mshare n/a+3.6% yoy
- Product And Service Other$56.1Mshare n/a-20.8% yoy
- Commission Members Approved In Prior Periods$44.4Mshare n/a+95.1% yoy
- Ancillaries$19.2Mshare n/a+78.2% yoy
- Small Business$11.1Mshare n/a-3.8% yoy
- Commission Revenue From Renewals$8.86Mshare n/a-7.3% yoy
- +2 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Commission$79.8Mshare n/a-19.3% yoy
- Medicare$70Mshare n/a-18.7% yoy
- Commission Members Approved During Current Period$69Mshare n/a-19.4% yoy
- Product And Service Other$8.21Mshare n/a-42.1% yoy
- Commission Members Approved In Prior Periods$8.03Mshare n/a-23.4% yoy
- Ancillaries$4.86Mshare n/a-16.6% yoy
- +4 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,104 US-listed filers · 898 in Financials| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $554M | 46thof 3,301 middle third | 53rdof 541 middle third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | 4.1% | 43rdof 3,135 middle third | 37thof 518 middle third |
Gross margin gross profit ÷ revenue | 43.5% | 58thof 1,603 middle third | 43rdof 59 middle third |
Operating margin operating income ÷ revenue | 12.0% | 72ndof 2,819 top third | 50thof 234 middle third |
Net margin net income ÷ revenue | 7.2% | 64thof 3,263 middle third | 37thof 534 middle third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | -5.0% | 26thof 2,679 bottom third | 21stof 307 bottom third |
Return on equity net income ÷ stockholders' equity (positive equity only) | 6.8% | 56thof 3,577 middle third | 40thof 774 middle third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 2.7% | 46thof 2,895 middle third | 56thof 422 middle third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 5 days | 94thof 2,398 top third | 88thof 104 top third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
Not available for EHTH yet: Earnings-quality fields arrive with this issuer's next re-crawl (sec_screen_v6)..
Point-in-time ledger
Not available for EHTH yet: The point-in-time ledger arrives with this issuer's next re-crawl (sec_screen_v6)..
Notes by disclosure type
Not available for EHTH yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.